Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 831

1.

Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina.

Bradbury BD, Lash TL, Kaye JA, Jick SS.

Cancer. 2005 Mar 15;103(6):1114-21.

PMID:
15712362
[PubMed - indexed for MEDLINE]
Free Article
2.

Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors.

Ford MB, Sigurdson AJ, Petrulis ES, Ng CS, Kemp B, Cooksley C, McNeese M, Selwyn BJ, Spitz MR, Bondy ML.

Cancer. 2003 Oct 1;98(7):1457-64.

PMID:
14508833
[PubMed - indexed for MEDLINE]
Free Article
3.

Tamoxifen and cataracts: a null association.

Bradbury BD, Lash TL, Kaye JA, Jick SS.

Breast Cancer Res Treat. 2004 Sep;87(2):189-96.

PMID:
15377843
[PubMed - indexed for MEDLINE]
4.

The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.

Lewis MA, Heinemann LA, Spitzer WO, MacRae KD, Bruppacher R.

Contraception. 1997 Sep;56(3):129-40.

PMID:
9347202
[PubMed - indexed for MEDLINE]
5.

Stroke risk and tamoxifen therapy for breast cancer.

Geiger AM, Fischberg GM, Chen W, Bernstein L.

J Natl Cancer Inst. 2004 Oct 20;96(20):1528-36.

PMID:
15494603
[PubMed - indexed for MEDLINE]
Free Article
6.

Cardiovascular effects of tamoxifen in women with and without heart disease: breast cancer prevention trial. National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial Investigators.

Reis SE, Costantino JP, Wickerham DL, Tan-Chiu E, Wang J, Kavanah M.

J Natl Cancer Inst. 2001 Jan 3;93(1):16-21.

PMID:
11136837
[PubMed - indexed for MEDLINE]
Free Article
7.

Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial. The Scottish Cancer Trials Breast Group.

McDonald CC, Alexander FE, Whyte BW, Forrest AP, Stewart HJ.

BMJ. 1995 Oct 14;311(7011):977-80.

PMID:
7580638
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.

Jakesz R, Greil R, Gnant M, Schmid M, Kwasny W, Kubista E, Mlineritsch B, Tausch C, Stierer M, Hofbauer F, Renner K, Dadak C, Rücklinger E, Samonigg H; Austrian Breast and Colorectal Cancer Study Group.

J Natl Cancer Inst. 2007 Dec 19;99(24):1845-53. Epub 2007 Dec 11. Erratum in: J Natl Cancer Inst. 2008 Feb 6;100(3):226.

PMID:
18073378
[PubMed - indexed for MEDLINE]
Free Article
9.

Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).

Mignotte H, Lasset C, Bonadona V, Lesur A, Luporsi E, Rodier JF, Cutuli B, Lasry S, Mauriac L, Granon C, Kerr C, Giard S, Hill C, de Lafontan B, de Gislain C, D'Anjou J, Fondrinier E, Lefeuvre C, Parache RM, Chauvin F.

Int J Cancer. 1998 May 4;76(3):325-30.

PMID:
9579567
[PubMed - indexed for MEDLINE]
10.

Tamoxifen therapy for breast cancer and endometrial cancer risk.

Bernstein L, Deapen D, Cerhan JR, Schwartz SM, Liff J, McGann-Maloney E, Perlman JA, Ford L.

J Natl Cancer Inst. 1999 Oct 6;91(19):1654-62.

PMID:
10511593
[PubMed - indexed for MEDLINE]
Free Article
11.

Risk of new primaries after chemotherapy and/or tamoxifen treatment for early breast cancer.

Rubagotti A, Perrotta A, Casella C, Boccardo F.

Ann Oncol. 1996 Mar;7(3):239-44.

PMID:
8740786
[PubMed - indexed for MEDLINE]
Free Article
12.

Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma.

Cristofanilli M, Yamamura Y, Kau SW, Bevers T, Strom S, Patangan M, Hsu L, Krishnamurthy S, Theriault RL, Hortobagyi GN.

Cancer. 2005 Mar 15;103(6):1122-8.

PMID:
15712375
[PubMed - indexed for MEDLINE]
Free Article
13.

Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers.

Cook LS, Weiss NS, Schwartz SM, White E, McKnight B, Moore DE, Daling JR.

J Natl Cancer Inst. 1995 Sep 20;87(18):1359-64.

PMID:
7658496
[PubMed - indexed for MEDLINE]
14.

Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis.

Brauchli YB, Jick SS, Miret M, Meier CR.

Br J Dermatol. 2009 May;160(5):1048-56. doi: 10.1111/j.1365-2133.2008.09020.x. Epub 2009 Feb 4.

PMID:
19210501
[PubMed - indexed for MEDLINE]
15.

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.

Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N.

J Natl Cancer Inst. 2005 Nov 16;97(22):1652-62.

PMID:
16288118
[PubMed - indexed for MEDLINE]
Free Article
16.

Myocardial infarction risk and tamoxifen therapy for breast cancer.

Geiger AM, Chen W, Bernstein L.

Br J Cancer. 2005 May 9;92(9):1614-20.

PMID:
15841078
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Contralateral breast cancer and thromboembolic events in African American women treated with tamoxifen.

McCaskill-Stevens W, Wilson J, Bryant J, Mamounas E, Garvey L, James J, Cronin W, Wickerham DL.

J Natl Cancer Inst. 2004 Dec 1;96(23):1762-9. Erratum in: J Natl Cancer Inst. 2005 Jan 5;97(1):71.

PMID:
15572758
[PubMed - indexed for MEDLINE]
Free Article
18.

Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.

Swerdlow AJ, Jones ME; British Tamoxifen Second Cancer Study Group.

J Natl Cancer Inst. 2005 Mar 2;97(5):375-84.

PMID:
15741574
[PubMed - indexed for MEDLINE]
Free Article
19.

Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan.

Matsuyama Y, Tominaga T, Nomura Y, Koyama H, Kimura M, Sano M, Miura S, Takashima S, Mitsuyama S, Ueo H, Ohashi Y.

Ann Oncol. 2000 Dec;11(12):1537-43.

PMID:
11205460
[PubMed - indexed for MEDLINE]
Free Article
20.

Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).

Beattie MS, Costantino JP, Cummings SR, Wickerham DL, Vogel VG, Dowsett M, Folkerd EJ, Willett WC, Wolmark N, Hankinson SE.

J Natl Cancer Inst. 2006 Jan 18;98(2):110-5.

PMID:
16418513
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk